A comprehensive profile of ChIp-Seq-Based PU.1/Spi1 target genes in microglia

Gene Regulation and Systems Biology

Volumn 8, Issue , 2014, Pages 127-139

  Satoh, Jun Ichi ^a   Asahina, Naohiro ^a   Kitano, Shouta ^a   Kino, Yoshihiro ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

ChIP seq; GenomeJack; KeyMolnet; Microglia; Microgliopathy; Nasu Hakola disease; PU.1; Spi1; Strand NGS

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FC RECEPTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SP1;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIOINFORMATICS; BONE MARROW CELL; BRAIN DAMAGE; CELL FUNCTION; CELL LOSS; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOCYTOSIS; GENE CONTROL; GENE IDENTIFICATION; GENE SEQUENCE; HOMEOSTASIS; INFLAMMATION; LYMPHOID CELL; LYSOSOME; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN MOTIF; STIMULUS RESPONSE;

MUS;

EID: 84937556516     PISSN: None     EISSN: 11776250     Source Type: Journal    
DOI: 10.4137/GRSB.S19711     Document Type: Article

References (45)

1. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol. 2011;11(11):775–87.
2. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841–5.
3. Schulz C, Perdiguero EG, Wieghofer P, et al. Microglia emerge from eryth­romyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013;16(3):273–80.
4. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193–201.
5. Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenera­tive disease. Nat Rev Immunol. 2014;14(7):463–77.
6. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of toll-like recep­tor signalling in Ab uptake and clearance. Brain. 2006;129(pt 11):3006–19.
7. Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol. 2008;9(8):857–65.
8. Béraud D, Twomey M, Bloom B, et al. α-Synuclein alters toll-like receptor expression. Front Neurosci. 2011;5:80.
9. Crotti A, Benner C, Kerman BE, et al. Mutant Huntingtin promotes autono­mous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513–21.
10. Turkistany SA, DeKoter RP. The transcription factor PU.1 is a critical regula­tor of cellular communication in the immune system. Arch Immunol Ther Exp (Warsz). 2011;59(6):431–40.
11. Pham TH, Minderjahn J, Schmidl C, et al. Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. Nucleic Acids Res. 2013;41(13):6391–402.
12. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15(20):5647–58.
13. Beers DR, Henkel JS, Xiao Q, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2006;103(43):16021–6.
14. Smith AM, Gibbons HM, Oldfield RL, et al. M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J Neuroinflammation. 2013;10:85.
15. Smith AM, Gibbons HM, Oldfield RL, et al. The transcription fac­tor PU.1 is critical for viability and function of human brain microglia. Glia. 2013;61(6):929–42.
16. Horiuchi M, Wakayama K, Itoh A, et al. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physi­ological phenotype of microglia. J Neuroinflammation. 2012;9:227.
17. Zusso M, Methot L, Lo R, Greenhalgh AD, David S, Stifani S. Regulation of postnatal forebrain amoeboid microglial cell proliferation and development by the transcription factor Runx1. J Neurosci. 2012;32(33):11285–98.
18. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet. 2009;10(10):669–80.
19. Satoh J, Kawana N, Yamamoto Y. Pathway analysis of ChIP-Seq-based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogen­esis of neurodegenerative diseases. Gene Regul Syst Bio. 2013;7:139–52.
20. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol. 1990;27(2–3):229–37.
21. Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.
22. Zhang X, Robertson G, Krzywinski M, et al. PICS: probabilistic inference for ChIP-seq. Biometrics. 2011;67(1):151–63.
23. Li L. GADEM: a genetic algorithm guided formation of spaced dyads coupled with an EM algorithm for motif discovery. J Comput Biol. 2009;16(2):317–29.
24. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analy­sis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
25. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integra­tion and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database Issue):D109–14.
26. Satoh J, Tabunoki H. Comprehensive analysis of human microRNA target net­works. BioData Min. 2011;4:17.
27. Jin H, Li L, Xu J, et al. Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression. Blood. 2012;119(22):5239–49.
28. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol. 2012;13(8):753–60.
29. Klünemann HH, Ridha BH, Magy L, et al. The genetic causes of basal gan­glia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology. 2005;64(9):1502–7.
30. Hickman SE, Kingery ND, Ohsumi TK, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16(12):1896–905.
31. Kierdorf K, Prinz M. Factors regulating microglia activation. Front Cell Neurosci. 2013;7:44.
32. Ginhoux F, Lim S, Hoeffel G, Low D, Huber T. Origin and differentiation of microglia. Front Cell Neurosci. 2013;7:45.
33. Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cul­tures or for animal experiments examining brain inflammation. ALTEX. 2009;26(2):83–94.
34. Rosenbauer F, Wagner K, Kutok JL, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 2004;36(6):624–30.
35. Rekhtman N, Choe KS, Matushansky I, Murray S, Stopka T, Skoultchi AI. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. Mol Cell Biol. 2003;23(21):7460–74.
36. Chen H, Ray-Gallet D, Zhang P, et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene. 1995;11(8):1549–60.
37. Wang D, D’Costa J, Civin CI, Friedman AD. C/EBPα directs monocytic com­mitment of primary myeloid progenitors. Blood. 2006;108(4):1223–9.
38. Friedman AD. C/EBPa induces PU.1 and interacts with AP-1 and NF-kB to regulate myeloid development. Blood Cells Mol Dis. 2007;39(3):340–3.
39. Gómez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci. 2013;33(6):2481–93.
40. Satoh J, Tabunoki H, Ishida T, et al. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Neuropathology. 2011;31(4):363–75.
41. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons with­out inflammation by microglial triggering receptor expressed on myeloid cells−2. J Exp Med. 2005;201(4):647–57.
42. Weigelt K, Ernst W, Walczak Y, et al. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J Leukoc Biol. 2007;82(6):1564–74.
43. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimu­lating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephal­opathy with spheroids. Nat Genet. 2011;44(2):200–5.
44. Zhang B, Gaiteri C, Bodea LG, et al. Integrated systems approach iden­tifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell. 2013;153(3):707–20.
45. Landt SG, Marinov GK, Kundaje A, et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012;22(9):1813–31.